Decision-Making for Patients With Cerebral Arteriovenous Malformations

Authors

Fawaz Al-Mufti, New York Medical CollegeFollow
Alan Stein
Nitesh Damodara
Ganaelle Joseph-Senatus
Rolla Nuoman
Halla Nuoaman
Yasir Ammar Adnan
Justin Santarelli, New York Medical CollegeFollow
Ramandeep Sahni, New York Medical College
Chirag D. Gandhi, New York Medical CollegeFollow

Author Type(s)

Faculty

DOI

10.1097/CRD.0000000000000342

Journal Title

Cardiology in Review

First Page

10

Last Page

14

Document Type

Review Article

Publication Date

1-2021

Department

Neurosurgery

Second Department

Neurology

Abstract

Cerebral arteriovenous malformations (AVMs) are a complex and heterogeneous pathology which require an understanding of the natural history of these lesions, as well as the potential treatment options in order to manage them safely. While treatment is the agreed upon strategy for most ruptured AVMs, the management of unruptured AVMs continues to be debated. More recently, this debate has been fueled by the A Randomized Trial of Unruptured Arteriovenous Malformations (ARUBA) trial which attempts to define the natural history and treatment risk of AVMs. However, the trial has significant shortcomings which limit its broad applicability. In addition, the breadth, efficacy, and safety of potential treatment options continue to improve. This review focuses on defining the natural history of cerebral AVMs, an overview of the ARUBA trial, and the most current treatment paradigm for cerebral AVMs.

Recommended Citation

Al-Mufti, F., Stein, A., Damodara, N., Joseph-Senatus, G., Nuoman, R., Nuoaman, H., Ammar Adnan, Y., Santarelli, J., Sahni, R., & Gandhi, C. D. (2021). Decision-Making for Patients With Cerebral Arteriovenous Malformations. Cardiology in Review, 29 (1), 10-14. https://doi.org/10.1097/CRD.0000000000000342